Drugs / WN/DEN4delta30
WN/DEN4delta30
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00537147 | Mar 2008 → Jun 2009 | West Nile fever | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | WN/DEN4delta30 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00537147 ↗ |
| Known as | West Nile/Dengue 4-3'delta30 Chimeric Virus Vaccine (WN/DEN4delta30) | “Phase 1 Study of the Safety and Immunogenicity of a 2-Dose Regimen of West Nile/Dengue 4-3'delta30 Chimeric Virus Vaccine (WN/DEN4delta30), a Live Attenuated Vaccine for West...” NCT00537147 ↗ |
| Modality | Vaccine | “live attenuated vaccine” NCT00537147 ↗ |
| Route | Subcutaneous | “administered as 0.5 ml subcutaneously in deltoid” NCT00537147 ↗ |